Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Respiratory Medicine, Fukuoka University School of Medicine, Fukuoka, Japan.
BMC Pulm Med. 2024 Nov 6;24(1):556. doi: 10.1186/s12890-024-03347-5.
We conducted a prospective observational study to elucidate the long-term prognosis and management of chronic obstructive pulmonary disease (COPD) in clinical practice in Japan in the mid-2010s.
This prospective cohort study included 29 facilities. Data from 427 patients clinically diagnosed with COPD, enrolled between September 2013 and April 2016, were analyzed. Interstitial pneumonia was excluded through a central multidisciplinary discussion. Follow-up data were collected for up to 5 years after patient registration.
At the time of registration, 53 patients clinically diagnosed with COPD did not have airflow limitation (AFL). In the cohort with AFL (n = 374), 232 patients completed a 5-year follow-up, while 49 patients died during the 1576.6 person-years of observation. The mean age was 71.7 years with an overall 5-year survival rate of 85.4%. Stratified by % forced expiratory volume in one second (FEV1), survival rates were 93.6% in the mild and moderate AFL group, 82.5% in the severe AFL group, and 66.1% in the very severe AFL group. The prognosis of the subpopulation without AFL was poor with a 5-year survival of 81.6%. This subpopulation exhibited respiratory symptoms, low vital capacity and total lung capacity, and emphysematous changes.
Our study presents the 5-year survival and real-world clinical practice scenario of a prospective cohort of patients clinically diagnosed with COPD in Japan in the mid-2010s. The survival rates of our cohort were numerically better than the Japanese cohort in the 1990s, regardless of the high median age of this cohort. Overall, 12.4% of the patients in this cohort with no AFL at registration exhibited respiratory symptoms and distinct spirometric patterns, and had a poor prognosis.
我们进行了一项前瞻性观察研究,旨在阐明 2010 年代中期日本临床实践中慢性阻塞性肺疾病(COPD)的长期预后和管理。
这项前瞻性队列研究包括 29 家机构。分析了 2013 年 9 月至 2016 年 4 月期间临床诊断为 COPD 的 427 例患者的数据。通过中央多学科讨论排除间质性肺炎。在患者登记后,最多可收集 5 年的随访数据。
在登记时,53 例临床诊断为 COPD 的患者没有气流受限(AFL)。在有 AFL 的队列中(n=374),232 例患者完成了 5 年随访,而在 1576.6 人年的观察期间有 49 例患者死亡。平均年龄为 71.7 岁,总体 5 年生存率为 85.4%。按第 1 秒用力呼气量(FEV1)%分层,轻度和中度 AFL 组的生存率为 93.6%,重度 AFL 组为 82.5%,非常重度 AFL 组为 66.1%。无 AFL 的亚组预后较差,5 年生存率为 81.6%。该亚组存在呼吸症状、肺活量和总肺容量低以及气肿性改变。
我们的研究提供了 2010 年代中期日本临床诊断为 COPD 的前瞻性队列患者的 5 年生存率和真实世界临床实践情况。无论该队列的中位年龄较高,其生存率在数值上均优于 20 世纪 90 年代的日本队列。总的来说,登记时无 AFL 的患者中有 12.4%存在呼吸症状和明显的肺功能模式,预后较差。